Inventaire - your friends and communities are your best library

Imaging amyloid deposition in Lewy body diseases

published in: Neurology

date of publication: 2008-09-01

language: English

Cites articles 38

Date

Title

Authors

2008-01-01

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

Sargo Aalto, Vesa Oikonen, Juha O. Rinne
2007-06-01

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

William E. Klunk, Howard J Aizenstein, Steven T Dekosky
2007-09-01

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Dennis W. Dickson, Bruno Dubois, Irene Litvan, Richard G Brown, David Burn, Dag Aarsland, Amos D. Korczyn, Ian G. McKeith, Werner Poewe, Eduardo Tolosa, Andrew John Lees, Christopher G. Goetz, Jeffrey L. Cummings, Niall P Quinn, Christina Sampaio, Charles Duyckaerts
2007-03-01

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

Dennis W. Dickson, Dag Aarsland, John Anthony Hardy, Charles Warren Olanow, Zbigniew K Wszolek, Eliezer Masliah
2007-03-01

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

William E. Klunk, Scott Raymond, Bradley Hyman, Matthew Frosch
2007-10-22

[11C]PIB binding in Parkinson's disease dementia.

Thomas Gasser, Daniela Berg, Walter Maetzler, Michel Mittelbronn
2007-10-17

A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies

Young-Sil An
2007-10-10

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Kerryn E. Pike, Paul Maruff, William E. Klunk, Greg Savage, Colin L. Masters
2007-09-01

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies

David Smith, Roberto Cappai, Catriona A. McLean
2007-09-01

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Eric E Smith, William E. Klunk, Jonathan Rosand
2007-05-01

Imaging beta-amyloid burden in aging and dementia

Kerryn E. Pike, Paul Maruff, William E. Klunk, Greg Savage, Clare Smith
2007-08-13

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis
2006-06-01

Neuropathology of older persons without cognitive impairment from two community-based studies

Raj C. Shah
2006-10-25

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

Alexander Hammers, Nick C. Fox, David J. Brooks, Rainer Hinz, Nicola Pavese, Martin Rossor
2006-06-28

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

Johannes Attems, Kurt Jellinger
2006-07-01

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

David J. Brooks, Nick C. Fox, Martin Rossor, Chris Frost, Josephine Barnes, Paul Edison, Hilary A Archer, Tom Yeatman
2006-03-01

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

William E. Klunk, David M. Holtzman, Anne M Fagan, Steven T. DeKosky, John C. Morris, Mark A. Mintun, Robert H Mach, Michael A Spinner
2006-08-01

[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease

William E. Klunk, Steven T Dekosky, John C. Morris, Mark A. Mintun
2005-10-19

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Ian G. McKeith, Dennis W. Dickson, John T. O'Brien, Howard Feldman, Dag Aarsland, Clive Ballard, David Burn, Glenda Halliday, Amos D. Korczyn, Irene Litvan, Florence Pasquier, Jörg B. Schulz, Elisabet Londos
2005-12-01

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

Steven T. DeKosky
2004-09-01

Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

Dag Aarsland, Clive Ballard, Glenda Halliday
2004-01-01

DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging.

David S Knopman, Ronald C. Petersen, Bradley F Boeve, Dennis W. Dickson
2003-06-01

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

William E. Klunk
2003-07-01

Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study.
2003-03-01

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component

Steven T Dekosky
2003-01-01

Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease.
2002-01

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

Nathalie Tzourio-Mazoyer, Bernard Mazoyer, Fabrice Crivello
2001-10-01

Cortical Lewy body pathology in the diagnosis of dementia.
2000-01-01

Cholinergic dysfunction in diseases with Lewy bodies.

Eliezer Masliah
1999-03-01

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.
1998-06-01

Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease.

Dennis W. Dickson, Matias Röyttä, Juha O. Rinne
1996-09-01

Distribution volume ratios without blood sampling from graphical analysis of PET data

Article - wd:Q37087766

Welcome to Inventaire

the library of your friends and communities

learn more